Science Explorer Back to mapMap
Institution · Tata Medical Center

Most cited papers from Tata Medical Center

What are the most cited papers from Tata Medical Center?

The most cited paper from Tata Medical Center is "Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer" (John Victor Heymach et al., 2023), with 780 citations. Next come "Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge" (545) and "Challenges to effective cancer control in China, India, and Russia" (510).

Showing 50 of 59 papers. Every paper with more than 61 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer John Victor Heymach et al. · New England Journal of Medicine Open access 23 Oct 2023 780
2 Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge Wouter Bulten et al. · Nature Medicine Open access 2022 545
3 Challenges to effective cancer control in China, India, and Russia Paul Edward Goss et al. · The Lancet Oncology Apr 2014 510
4 The growing burden of cancer in India: epidemiology and social context Mohandas K. Mallath et al. · The Lancet Oncology 11 Apr 2014 450
5 Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria? Martin Exner, Sanjay Bhattacharya, B. Christiansen et al. · PubMed Open access 10 Apr 2017 438
6 Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study Antonio Passaro et al. · Annals of Oncology Open access 23 Oct 2023 437
7 Global Retinoblastoma Presentation and Analysis by National Income Level Global Retinoblastoma Study Group et al. · JAMA Oncology Open access473 authors 27 Feb 2020 382
8 Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia Franco Locatelli et al. · JAMA Open access 2 Mar 2021 345
9 Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial Sebastian Grosicki et al. · The Lancet Open access Nov 2020 339
10 The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group Khalid El Bairi et al. · npj Breast Cancer Open access554 authors Dec 2021 288
11 Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia Viktoras Frismantas et al. · Blood Open access 25 Jan 2017 264
12 Changes in End-of-Life Practices in European Intensive Care Units From 1999 to 2016 Charles L. Sprung et al. · JAMA Open access 2 Oct 2019 261
13 International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic Charlotte Elizabeth Coles, Cynthia Aristei, Judith M. Bliss et al. · Clinical Oncology Open access 30 Mar 2020 258
14 The Genetic Basis of Hepatosplenic T-cell Lymphoma Matthew McKinney et al. · Cancer Discovery Open access 25 Jan 2017 206
15 An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome Christine J. Harrison et al. · Leukemia Open access 29 Oct 2013 204
16 Radiomics-based Machine-learning Models Can Detect Pancreatic Cancer on Prediagnostic Computed Tomography Scans at a Substantial Lead Time Before Clinical Diagnosis Sovanlal Mukherjee, Anurima Patra, Hala Khasawneh et al. · Gastroenterology Open access Jul 2022 188
17 Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study Alexander Avidan et al. · The Lancet Respiratory Medicine Open access 6 Aug 2021 181
18 Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience Sonam Vijay, Nitin Kumar Bansal, Brijendra Kumar Rao et al. · Infection and Drug Resistance Open access May 2021 177
19 Federated benchmarking of medical artificial intelligence with MedPerf Alexandros Karargyris et al. · Nature Machine Intelligence Book chapterOpen access 17 Jul 2023 173
20 Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists Wouter Bulten et al. · Modern Pathology Open access 5 Aug 2020 173
21 Impact of COVID-19 on cancer care in India: a cohort study Priya Ranganathan et al. · The Lancet Oncology Open access 27 May 2021 165
22 Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration Samuel C. Y. Leung et al. · npj Breast Cancer Open access 17 May 2016 158
23 Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines Hisham Mohamed Mehanna, Mark Dennis Evans, Matthew R. Beasley et al. · The Journal of Laryngology & Otology Open access May 2016 157
24 Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency Anirban Das et al. · Nature Medicine Open access 2022 155
25 Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia Julie Anne Elizabeth Irving et al. · Blood Open access 27 May 2016 138
26 Heating, ventilation and air conditioning (HVAC) in intensive care unit Sai Saran, Mohan Gurjar, Arvind Kumar Baronia et al. · Critical Care Open access 6 May 2020 129
27 Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data Paul Andrew Cohen et al. · Gynecologic Oncology ReviewOpen access 19 May 2019 126
28 An Advanced Deep Learning Approach for Ki-67 Stained Hotspot Detection and Proliferation Rate Scoring for Prognostic Evaluation of Breast Cancer Monjoy Saha, Chandan Chakraborty, Indu Arun et al. · Scientific Reports Open access 6 Jun 2017 123
29 Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration Samuel C. Y. Leung et al. · Histopathology Open access 24 Apr 2019 110
30 History of the Growing Burden of Cancer in India: From Antiquity to the 21st Century Robert Dean Smith, Mohandas K. Mallath · Journal of Global Oncology Open access 2 Aug 2019 109
31 Epidemiology of Non-Hodgkin's Lymphoma in India Reena Nair, Neeraj Arora, Mohandas K. Mallath · Oncology 2016 109
32 Ultrasound-Guided Continuous Quadratus Lumborum Block for Postoperative Analgesia in a Pediatric Patient Arunangshu Chakraborty, Jyotsna Goswami, Viplab Patro · A & A Case Reports Feb 2015 109
33 Rituximab in the treatment of systemic sclerosis–related interstitial lung disease: a systematic review and meta-analysis Rudra Prosad Goswami, Animesh Ray, Moumita Chatterjee et al. · Lara D. Veeken Review 31 Jul 2020 107
34 Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC Pasi Antero Janne et al. · New England Journal of Medicine 17 Oct 2025 105
35 Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations Jaya Singh et al. · Breast Cancer Research and Treatment 22 Feb 2018 102
36 A subtype of cancer-associated fibroblasts with lower expression of alpha-smooth muscle actin suppresses stemness through BMP4 in oral carcinoma Ankit Kumar Patel, Kavya Vipparthi, Venu Thatikonda et al. · Oncogenesis Open access 3 Oct 2018 98
37 Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial Daniel S.W. Tan et al. · Journal of Clinical Oncology Dec 2023 92
38 Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma Indu Arun, Namrata Maity, Shahin Hameed et al. · Head & Neck 6 Oct 2020 90
39 Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study) Arunaloke Chakrabarti, Harsimran Kaur, Jayanthi Savio et al. · Journal of Critical Care 5 Feb 2019 90
40 Health-care-associated bloodstream and urinary tract infections in a network of hospitals in India: a multicentre, hospital-based, prospective surveillance study Purva Mathur et al. · The Lancet Global Health Open access104 authors 9 Aug 2022 88
41 Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India Nandana Das, Shripad Dinanath Banavali, Sameer Bakhshi et al. · Trials Open access 31 Jan 2022 88
42 Variations in antibiotic use across India: multi-centre study through Global Point Prevalence survey Sanjeev Singh, Shubhashis Sengupta, Reena Antony et al. · Journal of Hospital Infection Open access 3 Jun 2019 83
43 Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems Ranjit Manchanda, Li Jiang Sun, Shreeya Patel et al. · Cancers Open access 17 Jul 2020 79
44 Ultrasound-guided truncal blocks: A new frontier in regional anaesthesia Arunangshu Chakraborty, Rakhi Khemka, Taniya Datta · Indian Journal of Anaesthesia Open access Oct 2016 78
45 Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem‐like properties to ovarian cancer cells Rahul Bhattacharya, Tulika Mitra, Susri Ray Chaudhuri et al. · Journal of Cellular Biochemistry 11 Nov 2017 77
46 A step-wise guide to performing survival analysis Santam Chakraborty · Cancer Research Statistics and Treatment Open access 2018 76
47 Oestrogen Receptor-α binds the FOXP3 promoter and modulates regulatory T-cell function in human cervical cancer Sreenivas Adurthi, Mahesh M. Kumar, H. S. Vinodkumar et al. · Scientific Reports Open access 5 Dec 2017 74
48 The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations Ashish Kumar, Subrat Kumar Acharya, Shivaram Prasad Singh et al. · Journal of Clinical and Experimental Hepatology Open access 22 May 2014 74
49 Automated Artificial Intelligence Model Trained on a Large Data Set Can Detect Pancreas Cancer on Diagnostic Computed Tomography Scans As Well As Visually Occult Preinvasive Cancer on Prediagnostic Computed Tomography Scans Panagiotis D. Korfiatis, Garima Suman, Nandakumar G. Patnam et al. · Gastroenterology Open access 30 Aug 2023 73
50 Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study Ayse B. Ercan et al. · The Lancet Oncology Open access128 authors 26 Mar 2024 72

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.